Epidemiology of extracutaneous melanoma in the Netherlands

Cancer Epidemiology Biomarkers and Prevention

Volumn 19, Issue 6, 2010, Pages 1453-1459

  Koomen, Els R ^a   De Vries, Esther ^b,e   Van Kempen, Leon C ^c,e   Van Akkooi, Alexander C J ^b,e   Guchelaar, Henk Jan ^a   Louwman, Marieke W J ^d   Nijsten, Tamar ^b   Coebergh, Jan Willem W ^b,d,e  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^d The Netherlands   (Netherlands)

^e EORTC DATA CENTER   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER INCIDENCE; CANCER REGISTRY; CANCER SURVIVAL; CONTROLLED STUDY; EYE MELANOMA; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MELANOMA; NETHERLANDS; POPULATION RESEARCH; PRIORITY JOURNAL; STANDARDIZATION; CENTRAL NERVOUS SYSTEM NEOPLASMS; EYE NEOPLASMS; HEAD AND NECK NEOPLASMS; INCIDENCE; MIDDLE AGED; SKIN NEOPLASMS; SURVIVAL;

ADULT; AGED; CENTRAL NERVOUS SYSTEM NEOPLASMS; EYE NEOPLASMS; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; INCIDENCE; MALE; MELANOMA; MIDDLE AGED; NETHERLANDS; SKIN NEOPLASMS; SURVIVAL ANALYSIS;

EID: 77953309127     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-09-1267     Document Type: Article

References (25)

1. Thoelke A, Willrodt S, Hauschild A, Schadendorf D. Primary extracutaneous malignant melanoma: a comprehensive review with emphasis on treatment. Onkologie 2004;27:492-9.
2. Ross MI, Stern SJ. Mucosal melanomas. In: Balch CM, Houghton AN, Milton GW, Sober AJ, Soong S-J, editors. Cutaneous melanoma. 3rd ed. Philadelphia: JB Lippincott; 1998, p. 195-206.
3. Ragnarson-Olding BK, Kanter-Lewensohn LR, Lagerlöf B, Nilsson BR, Ringborg UK. Malignant melanoma of the vulva in a nationwide, 25-year study of 219 Swedish female: clinical observations and histopathological features. Cancer 1999;86:1273-84.
4. van Geel AN, den Bakker MA, Kirkels W, et al. Prognosis of primary penile melanoma: a series of 19 Dutch patients and 47 patients from literature. Urology 1997;70:143-7.
5. Margo CE. The collaborative ocular melanoma study: an overview. Cancer Control 2004;11:304-9.
6. McLaughlin CC, Wu XC, Jemal A, Martin HJ, Roche LM, Chen VW. Incidence of noncutaneous melanomas in the U.S. Cancer 2005;103: 1000-7.
7. de Vries E, Schouten LJ, Visser O, Eggermont AMM, Coebergh JWW, Working Group of Regional Cancer Registries. Rising trends in the incidence of and mortality from cutaneous melanoma in the Netherlands: a northwest to southeast gradient? Eur J Cancer 2003;39:1439-46.
8. Siesling S, van der Aa MA, Coebergh JWW, Pukkala E. Time-space trends in cancer incidence in the Netherlands in 1989-2003. Int J Cancer 2008;122:2106-14.
9. Parkin D, Whelan S, Ferlay J, Raymond L, Young J, editors. Cancer Incidence in 5 Continents. 7. Lyon: International Agency for Research on Cancer; 1997.
10. Kim HJ, Fay MP, Feuer EJ, Midthune DN. Permutation tests for joinpoint regression with applications to cancer rates. Stat Med 2000;19:335-51.
11. Hakulinen T, Abeywickrama KH. A computer program package for relative survival analysis. Comput Programs Biomed 1985;19: 197-207. (Pubitemid 15098487)
12. Greenwood M. A Report on the Natural Duration of Cancer. London: Ministry of Health HMSO; 1926.
13. Peter RU, Landthaler M, Braun-Falco O. Extracutaneous malignant melanoma: clinical aspects and biology. Hautarzt 1992;43:535-41.
14. Chang AE, Karnell LH, Menck HR, The American College of Surgeons Commission on Cancer and the American Cancer Society. The National Cancer Data Base report on cutaneous and noncutaneous melanoma: a summary of 84,836 cases from the past decade. Cancer 1998;83:1664-78.
15. De Matos P, Tyler DS, Seigler HF. Malignant melanoma of the mucous membranes: a review of 119 cases. Ann Surg Oncol 1998; 5:733-42.
16. Weinstock MA. Malignant melanoma of the vulva and vagina in the United States: patterns of incidence and population-based estimates of survival. Am J Obstet Gynecol 1994;171:1225-30.
17. Roumen RMH. Anorectal melanoma in The Netherlands: a report of 63 patients. Eur J Surg Oncol 1996;22:598-601. (Pubitemid 27036200)
18. Viros A, Fridlyand J, Bauer J, et al. Improving melanoma classification by integrating genetic and morphologic features. PloS Medicine 2008;5:941-52.
19. Curtin JA, Fridlyand J, Kageshita T, et al. Distinct sets of genetic alterations in melanoma. N Eng J Med 2005;353:2135-47.
20. Rimoldi D, Salvi S, Liénard D, et al. Lack of BRAF mutations in uveal melanoma. Cancer Res 2003;63:5712-5.
21. Wong CW, Fan YS, Chan TL, et al. BRAF and NRAS mutations are uncommon in melanomas arising in diverse internal organs. J Clin Pathol 2005;58:640-4.
22. Maat W, Kilic E, Luyten GP, et al. Pyrophosphorolysis detects B-RAF mutations in primary uveal melanoma. Invest Ophtamol Vis Sci 2008; 49:23-7.
23. Janssen CS, Sibbett R, Henriquez FL, McKay IC, Kemp EG, Roberts F. The T1799A point mutation is present in posterior uveal melanoma. Br J Cancer 2008;99:1673-7.
24. Van Raamsdonk CD, Bezrookove V, Green G, et al. Frequent somatic mutations of GNAQ in uveal melanoma and blue naevi. Nature 2009; 457:599-603.
25. Curtin JA, Busam K, Pinkel D, Bastian BC. Somatic activation of KIT in distinct subtypes of melanoma. J Clin Oncol 2006;24: 4340-6.